gi-hepatology
EVendo Score for Predicting Esophageal Varices
Non-invasive score to predict the presence of oesophageal varices (OV) in patients with chronic liver disease or cirrhosis, avoiding unnecessary endoscopy. Based on platelet count, spleen diameter, and albumin. Score below 3.90 has high negative predictive value (NPV) for ruling out varices needing treatment (VNT). From Marot et al. 2019.
References
- Marot A et al. EVendo score: a clinical tool for the non-invasive assessment of oesophageal varices in patients with liver cirrhosis. United European Gastroenterol J. 2019;7(4):485-495.
- de Franchis R, Bosch J et al. Baveno VII -- Renewing consensus in portal hypertension. J Hepatol. 2022;76(4):959-974.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Propranolol (Portal Hypertension) · Antihypertensive
- Carvedilol (Portal Hypertension) · Non-Selective Beta-Blocker with Alpha₁-Blocking Activity
- Selexipag · Pulmonary Arterial Hypertension
- Macitentan · Pulmonary Arterial Hypertension
- Spironolactone (Ascites / Cirrhosis) · Aldosterone Antagonist / Potassium-Sparing Diuretic
- Furosemide (Ascites / Cirrhosis) · Loop Diuretic
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.